MyFinsight

HomeCompareAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Privacy Policy
  • Contact

Follow Us

  • Thread
  • X.com
  • Instagram

© 2026 MyFinsight. All rights reserved.

Recent SEC Filings
10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)
||
||

Income Overview

Net Income
-$1,794,863
EPS
-$0.02
Unit: Dollar
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
363,127
491,134
3,813,703.5*
1,517,723
General and administrative
1,445,739
1,668,454
5,361,934.5*
1,130,764
Total operating expenses
1,808,866
2,159,588
9,175,638
2,648,487
Loss from operations
-1,808,866
-2,159,588
-9,175,638*
-2,648,487
Warrant repricing
-
410,154
-
-
Other income, net
14,003
28,672
56,065.5*
39,088
Change in fair value of convertible promissory notes
-
-
576,710.5*
-365,718
Total other income (expense)
14,003
-381,482
-
-
Net loss
-1,794,863
-2,541,070
-8,542,862
-2,975,117
Basic EPS
-0.02
-0.23
-8.842
-2.98
Diluted EPS
-0.02
-0.23
-8.842
-2.98
Basic Average Shares
116,131,213
10,956,650
966,124*
997,038
Diluted Average Shares
116,131,213
10,956,650
966,124*
997,038
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

INDP Income Statement Sankey DiagramSankey diagram visualizing INDP income statement for the periodOther income, net$14,003 (-9.93%↓ Y/Y)Net loss-$1,794,863 (65.67%↑ Y/Y)Total other income(expense)$14,003 Loss from operations-$1,808,866 (59.41%↑ Y/Y)Total operatingexpenses$1,808,866 (-59.41%↓ Y/Y)General andadministrative$1,445,739 (-36.86%↓ Y/Y)Research and development$363,127 (-83.24%↓ Y/Y)

Indaptus Therapeutics, Inc. (INDP)

Indaptus Therapeutics, Inc. (INDP)